Novo Nordisk successfully prices Euro medium term notes worth EUR 1.3bn

The proceeds will be used for general corporate purposes, including the refinancing of a bridge loan.

Photo: Jacob Gronholt-Pedersen/REUTERS / X04292

Novo Nordisk has successfully priced EUR 1.3bn (USD 1.6bn) notes, according to a press release published on Thursday.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs